The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 6, 2015

Primary Completion Date

December 11, 2016

Study Completion Date

December 11, 2016

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Calcium Carbonate

Calcium carbonate was obtained from Pharmacy Department, Faculty of Medicine, University of Indonesia. Subjects were randomized to receive calcium carbonate or placebo for 12 weeks.

DRUG

Placebo oral capsule

Placebo oral capsule was also obtained from Pharmacy Department, Faculty of Medicine, University of Indonesia. Subjects were randomized to receive calcium carbonate or placebo for 12 weeks.

Trial Locations (1)

10430

dr. Cipto Mangunkusumo Hospital, Jakarta Pusat

All Listed Sponsors
collaborator

Dr Cipto Mangunkusumo General Hospital

OTHER

lead

Indonesia University

OTHER

NCT03550534 - The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia | Biotech Hunter | Biotech Hunter